Sunniva Responds To Filing Of Notice Of Claim With Respect To Finder’s Fee Agreement

Published on: January 2, 2020

VANCOUVER, British ColumbiaJan. 2, 2020 /PRNewswire/ — Sunniva Inc. (“Sunniva”, the “Company”) (CSE: SNN) (OTCQB: SNNVF), has become aware that it has been named in a lawsuit (the “Lawsuit”), commenced in connection with amounts payable to IMK Management Services Inc. (the “Plaintiff”) under a Finder’s Fee Agreement (the “Agreement”) dated January 28, 2019 with respect to the sale of Natural Health Services (“NHS”). The sale of NHS was completed on December 18, 2019. A notice of civil claim was filed in the Supreme Court of British Columbia on December 30, 2019 in respect of the Lawsuit. The Plaintiff is seeking judgement for an alleged amount due under the Agreement of CA $472,500. Sunniva has 21 days to respond to the notice of civil claim.

For more information about the Company please visit: www.sunniva.com.

To be added to the Sunniva email distribution list please register at www.sunniva.com/email-alerts.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Information or Statements

This press release contains forward-looking information or statements. All statements that are or information which is not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, statements regarding Sunniva’s operations and growth opportunities are “forward-looking information or statements”. Forward-looking information or statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. With respect to forward-looking information and statements contained herein, Sunniva has made numerous assumptions including, among other things, assumptions about general business and economic conditions. Such forward-looking statements are based on assumptions and involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking information or statements. Such risks and uncertainties include, among others, the risk factors included in the Sunniva’s continuous disclosure documents available on www.sedar.com. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking information or statements. Although Sunniva has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking information or statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking information or statements. Sunniva assumes no obligation to update any forward-looking information or statements, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.

Company Contacts:

Sunniva Inc.

Sunniva Investor Relations Contact:      

Dr. Anthony Holler

Rob Knowles

Chairman and Chief Executive Officer

VP Corporate Development

Phone: (866) 786-6482

Phone: (587) 430-0680  

Email: [email protected]

Cannabis Healthcare Pharmaceutical